Choudhury N, Hariri A, Saleh H
Department of ENT,East Surrey Hospital,London,UK.
Department of ENT,Manchester Royal Infirmary Hospital,UK.
J Laryngol Otol. 2016 Sep;130(9):827-32. doi: 10.1017/S0022215116008483. Epub 2016 Jul 18.
The endoscopic modified Lothrop procedure is mainly used for refractory frontal sinusitis. However, we have used it as an access procedure to facilitate treatment for an extended range of additional frontal sinus pathologies.
A retrospective review of patients who underwent the endoscopic modified Lothrop procedure for 'alternative' frontal sinus pathologies was conducted. Patient data were reviewed. The main outcome parameter measured was signs of recurrence.
Twelve patients (6 males, 6 females) from a 7-year study period, with a mean age of 45.2 years (range, 16-78 years), were analysed. The surgical indications included frontoethmoidal mucoceles, cerebrospinal fluid leaks within the frontal sinus, cystic fibrosis, frontal sinus osteoma, frontal sinus ossifying fibroma and frontal silent sinus syndrome. The mean follow-up period was 33.3 months. There were no known recurrences.
We have used the endoscopic modified Lothrop procedure for a range of frontal sinus pathologies, safely and effectively, with no peri-operative complications.
内镜改良Lothrop手术主要用于治疗难治性鼻窦炎。然而,我们已将其作为一种入路手术,以方便对更多类型的额窦病变进行治疗。
对因“其他”额窦病变接受内镜改良Lothrop手术的患者进行回顾性研究。回顾患者数据。测量的主要结局参数为复发迹象。
分析了7年研究期间的12例患者(6例男性,6例女性),平均年龄45.2岁(范围16 - 78岁)。手术适应证包括额筛窦黏液囊肿、额窦内脑脊液漏、囊性纤维化、额窦骨瘤、额窦骨化纤维瘤和额窦静息窦综合征。平均随访期为33.3个月。无已知复发情况。
我们已将内镜改良Lothrop手术用于一系列额窦病变,安全有效,且无围手术期并发症。